Latest filing published 23 Apr 2014 for Immunic, INC., €13k.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +131.2%Entry US$4,956.00 · Close at T+365 US$11,460.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Philip M. Croxford: trading record in brief
All filings by Philip M. Croxford on record concern Immunic, Inc. Altogether 2 filings, all relating to 23 April 2014.
Purchases make up the whole of the open-market record (1 purchase, €13k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
The latest filing, published on 23 April 2014, reports an open-market purchase of €13k in Immunic, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Philip M. Croxford
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,500 shares@ US$12.00Common StockSEC:0001209191-14-028937:0Canonical exit: 22 Jul 2014 (T+90)
- 7,250 sharesCommon StockSEC:0001209191-14-028937:1
2 of 2 declarations